Login / Signup

The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT Trial.

Chitapa KaveetaIbrahim AlhabliFouzi BalaMacKenzie HornFaysal BenaliShelagh B CouttsAtif ZafarOlena BereznyakovaAlexander V KhawHouman KhosravaniGary R HunterAleksander TkachDariush DowlatshahiLuciana CataneseChrysi BogiatziRamana AppireddyBrian BuckRichard H SwartzTolulope SajobiMohammed AlmekhlafiAndrew M DemchukJennifer A FronteraBijoy K MenonNishita Singh
Published in: International journal of stroke : official journal of the International Stroke Society (2024)
Similar to prior studies, we found that every one-point decrease in ASPECTS was associated with poorer clinical and safety outcomes. This effect did not differ between alteplase and tenecteplase.
Keyphrases
  • clinical trial
  • study protocol
  • randomized controlled trial
  • metabolic syndrome
  • phase iii
  • adipose tissue
  • insulin resistance
  • skeletal muscle
  • combination therapy
  • case control
  • open label
  • smoking cessation
  • double blind